Chakravarthy Manu 4
4 · Axcella Health Inc. · Filed Feb 3, 2021
Insider Transaction Report
Form 4
Chakravarthy Manu
SVP & Chief Medical Officer
Transactions
- Sale
Common Stock
2021-02-01$5.50/sh−18,472$101,631→ 41,528 total - Exercise/Conversion
Common Stock
2021-02-01+60,000→ 60,000 total - Exercise/Conversion
Restricted Stock Units
2021-02-01+60,000→ 60,000 total→ Common Stock (60,000 underlying)
Footnotes (4)
- [F1]Each restricted stock unit represents a contingent right to receive one share of AXLA common stock.
- [F2]Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of the RSUs listed in Table II and does not represent a discretionary trade by the reporting person.
- [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.38 to $5.68, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
- [F4]The restricted stock units vested in full on February 1, 2021.